Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16685353 | 1.00 | GCK (0.35) | GCKMEN1KMT2APRKCA | |
| SCHEMBL16685352 | 0.83 | ACACB (0.45) | GCKMEN1KMT2A | |
| SCHEMBL16685199 | 0.81 | MEN1 (0.33) | GCKMEN1KMT2A | |
| SCHEMBL23023778 | 0.81 | MEN1 (0.33) | GCKMEN1KMT2A | |
| SCHEMBL12911516 | 0.79 | GCK (0.34) | GCKMEN1KMT2A | |
| SCHEMBL18047458 | 0.76 | GCK (0.35) | GCKMEN1KMT2A | |
| SCHEMBL16685525 | 0.76 | GCK (0.35) | GCKMEN1KMT2A | |
| SCHEMBL16693378 | 0.74 | GCK (0.31) | GCK | |
| SCHEMBL16685394 | 0.74 | GCK (0.31) | GCK | |
| SCHEMBL29714028 | 0.74 | PRKCA (0.35) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643418-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11643418-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| EP-3689881-B1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MAN CO LTD (JP) | 2022-01-12 | — | — | EP | disclosed |
| US-20210188867-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-06-24 | — | — | US | disclosed |
| US-10934307-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-03-02 | — | — | US | disclosed |
| EP-3689881-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | Eisai R&D Management Co., Ltd. (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20200223864-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-07-16 | — | — | US | disclosed |
| US-10611773-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| EP-3066102-B1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MAN CO LTD (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-20190144463-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| US-10221189-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-03-05 | — | — | US | disclosed |
| US-20180002342-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20180002342-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9783549-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9783549-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2017-10-10 | — | — | US | disclosed |
| US-20160264594-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160264594-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| WO-2015066729-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002342-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, DHPS, ELOB | GCK 730/4885MEN1 214/4885KMT2A 4155/4885 |
| US-20160264594-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, DHPS, ELOB | GCK 559/4885MEN1 166/4885KMT2A 4122/4885 |
| US-20190144463-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | GCK 817/4885MEN1 131/4885KMT2A 4252/4885 |
| US-20200223864-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | GCK 817/4885MEN1 131/4885KMT2A 4252/4885 |
| US-10934307-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | GCK 817/4885MEN1 131/4885KMT2A 4252/4885 |
| US-11643418-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | GCK 608/4885MEN1 92/4885KMT2A 4203/4885 |
| US-10611773-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | GCK 817/4885MEN1 131/4885KMT2A 4252/4885 |
| US-20210188867-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | GCK 608/4885MEN1 92/4885KMT2A 4203/4885 |
| US-10221189-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | ERLIN1, DHPS, ELOB | GCK 730/4885MEN1 214/4885KMT2A 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.